We are live on ! Find out more
SA

Sovran Advisors Portfolio holdings

AUM $1.34B
1-Year Est. Return 21.63%
This Fund
S&P 500
This Quarter Est. Return
+1.28%
1 Year Est. Return
+21.63%
3 Year Est. Return
–
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$1.18B
AUM Growth
+$45.3M
Cap. Flow
+$31.6M
Cap. Flow %
2.69%
Top 10 Hldgs %
18.09%
Holding
582
New
63
Increased
234
Reduced
235
Closed
31
Avg Time Held
2.9 quarters
Top 10 Avg Time Held
2.9 quarters
Top 20 Avg Time Held
2.9 quarters

Sector Composition

Rank Sector Weight
1 Miscellaneous 71.4%
2 Technology 11.45%
3 Financials 4.01%
4 Communication Services 3.03%
5 Consumer Discretionary 2.65%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow Held Since
ES icon
476
Eversource Energy
ES
$24.8B
$258K 0.02%
3,707
+851
+30% +$59.8K
2025 Q3
1 quarter
XOCT icon
477
FT Vest US Equity Enhance & Moderate Buffer ETF October
XOCT
$40.5M
$257K 0.02%
6,764
– –
2025 Q3
1 quarter
SNA icon
478
Snap-on
SNA
$18.8B
$256K 0.02%
705
+86
+14% +$29.4K
2025 Q3
1 quarter
TMO icon
479
Thermo Fisher Scientific
TMO
$245B
$256K 0.02%
410
+10
+3% +$5.66K
2025 Q3
1 quarter
ROST icon
480
Ross Stores
ROST
$72.1B
$255K 0.02%
1,316
-9
-0.7% -$1.5K
2025 Q3
1 quarter
CE icon
481
Celanese
CE
$4.91B
$255K 0.02%
5,404
-3,945
-42% -$161K
2025 Q1
3 quarters
CCJ icon
482
Cameco
CCJ
$37.5B
$253K 0.02%
2,241
-171
-7% -$15.4K
2025 Q3
1 quarter
QTEC icon
483
First Trust NASDAQ-100 Technology Index Fund
QTEC
$3.96B
$250K 0.02%
1,054
-192
-15% -$44.8K
2025 Q2
2 quarters
BKNG icon
484
Booking.com
BKNG
$118B
$249K 0.02%
1,200
-1,875
-61% -$386K
2025 Q2
2 quarters
VRCA icon
485
Verrica Pharmaceuticals
VRCA
$61.5M
$249K 0.02%
32,658
-41,147
-56% -$228K
2024 Q4
4 quarters
PH icon
486
Parker-Hannifin
PH
$120B
$247K 0.02%
262
-18
-6% -$14.7K
2025 Q3
1 quarter
CCL icon
487
Carnival Corporation Ltd
CCL
$35.9B
$247K 0.02%
8,379
+100
+1% +$2.79K
2025 Q2
2 quarters
AOS icon
488
A.O. Smith
AOS
$7.87B
$246K 0.02%
+3,419
New +$231K
2025 Q4
0 quarters
MISL icon
489
First Trust Indxx Aerospace & Defense ETF
MISL
$767M
$243K 0.02%
+4,850
New +$203K
2025 Q4
0 quarters
PSMD icon
490
Pacer Swan SOS Moderate January ETF
PSMD
$95.7M
$240K 0.02%
+7,339
New +$235K
2025 Q4
0 quarters
FHLC icon
491
Fidelity MSCI Health Care Index ETF
FHLC
$3.44B
$240K 0.02%
3,182
-128
-4% -$9.22K
2024 Q4
4 quarters
GD icon
492
General Dynamics
GD
$89.9B
$239K 0.02%
649
-19
-3% -$6.48K
2025 Q3
1 quarter
CL icon
493
Colgate-Palmolive
CL
$71.7B
$239K 0.02%
+2,836
New +$222K
2025 Q4
0 quarters
TIP icon
494
iShares TIPS Bond ETF
TIP
$14.3B
$239K 0.02%
2,169
-99
-4% -$11K
2024 Q4
4 quarters
SPDW icon
495
State Street SPDR Portfolio Developed World ex-US ETF
SPDW
$40.7B
$237K 0.02%
5,144
– –
2024 Q4
4 quarters
AFL icon
496
Aflac
AFL
$58.4B
$237K 0.02%
+2,165
New +$238K
2025 Q4
0 quarters
ADP icon
497
Automatic Data Processing
ADP
$109B
$235K 0.02%
+902
New +$240K
2025 Q4
0 quarters
IWO icon
498
iShares Russell 2000 Growth ETF
IWO
$13.9B
$235K 0.02%
674
– –
2025 Q3
1 quarter
SBUX icon
499
Starbucks
SBUX
$105B
$235K 0.02%
2,515
-1,404
-36% -$118K
2024 Q4
4 quarters
CAH icon
500
Cardinal Health
CAH
$55.5B
$233K 0.02%
1,093
+24
+2% +$4.52K
2025 Q3
1 quarter

Similar funds

Sovran Advisors's Q4 2025 Portfolio in Review

As of Q4 2025, Sovran Advisors held 582 positions worth $1.18B, up 4% from $1.13B the previous quarter. Its ten largest holdings account for 18% of the portfolio.

Sovran Advisors's Q4 2025 filing shows 63 new, 234 increased, 235 reduced and 31 closed positions. Its largest new stake was CoreWeave: 70,438 shares worth $6.69M. The largest sale was Ionis Pharmaceuticals, an estimated $11.2M.

By sector, the portfolio is most concentrated in Miscellaneous at 71% of assets, down from 72% a quarter earlier, followed by Technology and Financials.

  • Sovran Advisors's largest Q4 2025 buy was CoreWeave: 70,438 shares worth $6.69M.
  • Sovran Advisors added most to Broadcom in Q4 2025, an estimated $6M increase.
  • Sovran Advisors's biggest Q4 2025 reduction was PIMCO RAFI Multi-Factor International Equity ETF, cutting an estimated $4.07M.
  • Sovran Advisors fully exited Ionis Pharmaceuticals in Q4 2025, selling an estimated $11.2M.
  • Sovran Advisors's ten largest holdings make up 18% of its $1.18B portfolio in Q4 2025.
  • Sovran Advisors opened 63 new positions and closed 31 in Q4 2025.
  • Sovran Advisors's portfolio value rose 4% quarter-over-quarter to $1.18B.

Based on Sovran Advisors's 13F filing for Q4 2025, filed 20 Jan 2026.